Clinical Trial Update: Copper Cu 64 TP3805 PET in Detecting Prostate Cancer in Patients With Persistently Elevated PSA [NA]

View source ↗

Summary

A completed clinical trial assessing Copper-64 TP3805 PET imaging for detecting prostate cancer in patients with persistently elevated PSA. Results have been po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Copper-64 TP3805 (Copper-64 TP3805)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Conditions: Prostate Cancer | NA | Status: COMPLETED | Results posted: 2025-03-27